Literature DB >> 6202347

Intra- and extraneuronal monoamine oxidase.

C J Fowler, O Magnusson, S B Ross.   

Abstract

By use of monoamine reuptake inhibitors, it is possible to study the intra- and extraneuronal components of monoamine deamination in brain. In both man and rat, the ratios of activities of MAO-A/MAO-B are higher intra- than extraneuronally . As a result of this difference in cellular localisation in the brain, loss of neurones produces a change in the ratios of activities of MAO-A/MAO-B. It is also possible selectively to inhibit the activity of MAO-A within a given neurone population. The alpha-methyl substituted monoamine amiflamine has been shown to inhibit MAO-A within serotoninergic neurones at lower doses than are required for inhibition in other neurones. The usefulness of this compound in the elucidation of the functions of intra- and extraneuronal MAO are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202347     DOI: 10.1159/000158505

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  4 in total

Review 1.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

2.  Inhibition of monoamine oxidase in 5-hydroxytryptaminergic neurones by substituted p-aminophenylalkylamines.

Authors:  A L Ask; I Fagervall; L Florvall; S B Ross; S Ytterborn
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

3.  Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).

Authors:  C J Fowler; M Eriksson; G Thorell; O Magnusson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

Review 4.  Fluoxetine: a review of receptor and functional effects and their clinical implications.

Authors:  C M Beasley; D N Masica; J H Potvin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.